GLS2 and cancer: Given the important role of transcription factor Forkhead box C2 (FOXC2) in maintaining stem cell-like features and mesenchymal phenotype, inhibition of FOXC2 expression and subsequent EMT inhibition could restore GLS2 expression as well as glutamine utilization in cancer cells undergoing EMT.